The 6 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 5.88, with a high estimate of 12.00 and a low estimate of 3.00. The median estimate represents a +2.89% increase from the last price of 5.71.
The current consensus among 7 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since January, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.56
Reporting Date Aug 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.